A pilot study of low-dose capecitabine plus trastuzumab as first-line treatment for patients older than 75 years with HER2-positive advanced gastric cancer.
Sun Jin Sym
No relevant relationships to disclose
Young Saing Kim
No relevant relationships to disclose
Inkeun Park
No relevant relationships to disclose
Hee Kyung Ahn
No relevant relationships to disclose
Junshik Hong
No relevant relationships to disclose
Jinny Park
No relevant relationships to disclose
Eun Kyung Cho
No relevant relationships to disclose
Jae Hoon Lee
No relevant relationships to disclose
Woon Ki Lee
No relevant relationships to disclose
Min Chung
No relevant relationships to disclose
Hyung-Sik Kim
No relevant relationships to disclose
Dong Bok Shin
No relevant relationships to disclose